About Encap Drug Delivery
Encap Drug Delivery is a Healthcare company based in Livingston (United Kingdom) founded in 2009, and was acquired by Capsugel in March 2013. Liquid and semi-solid filled capsules are developed and manufactured. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.
Company details
Encap Drug Delivery is a developer and manufacturer of liquid and semi-solid filled capsules . Their development services include CMC consultancy, Analytical method transfer, Pre-formulation and Formulation development. It offers its services for the development of Poorly soluble drugs, Hygroscopic and oxidation sensitive compounds, Highly potent and cytotoxic APIs, Immediate, controlled and sustained release formulations. The company caters to clinical trial manufacturing needs (Phase I to IV) and for full commercial scale manufacturing. They have capabilities for highly potent and cytotoxic products and high containment manufacturing. They have technologies such as Capsule-in-capsule, Colonic Delivery, Abuse deterrent formulations for drug development. In 2013, the company was acquired by US based Capsugel, a CDMO offering innovative dosage forms and solutions.
- Headquarters Livingston, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website encapdrugdelivery.com
- Social LinkedIn X
- Acquired by Capsugel (Mar 2013)
Investors in Encap Drug Delivery
Encap Drug Delivery has secured backing from 1 investor. Prominent investors backing the company include Capsugel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Dosage forms are delivered for preclinical, clinical, and commercial supply. | 1875 | capsugel.com | Morristown, United States |
Investor details for Encap Drug Delivery
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Encap Drug Delivery
2 dated milestones of Encap Drug Delivery across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Encap Drug Delivery is founded.
- Exit Acquired by Capsugel.
Web traffic of Encap Drug Delivery
Websites that share an audience with Encap Drug Delivery (encapdrugdelivery.com).
Websites whose visitors overlap most with Encap Drug Delivery. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
yds.ypsomed.com | yds.ypsomed.com | 100% | – | ||
| neostx.com | 98% | View details | |||
| catalent.com | 97% | 116.7K | #338,870 | View details | |
| ethypharm.com | 97% | 3.5K | #6,712,435 | View details | |
oindpnews.com | oindpnews.com | 97% | #3,560,291 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for Encap Drug Delivery
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Encap Drug Delivery
Encap Drug Delivery was founded in 2009.
Encap Drug Delivery is headquartered in Livingston, United Kingdom. It is registered at Livingston, Scotland, United Kingdom.
Encap Drug Delivery is a developer and manufacturer of liquid and semi-solid filled capsules . Their development services include CMC consultancy, Analytical method transfer, Pre-formulation and Formulation development. It offers its services for the development of Poorly soluble drugs, Hygroscopic and oxidation sensitive compounds, Highly potent and cytotoxic APIs, Immediate, controlled and sustained release formulations. The company caters to clinical trial manufacturing needs (Phase I to IV) and for full commercial scale manufacturing. They have capabilities for highly potent and cytotoxic products and high containment manufacturing. They have technologies such as Capsule-in-capsule, Colonic Delivery, Abuse deterrent formulations for drug development. In 2013, the company was acquired by US based Capsugel, a CDMO offering innovative dosage forms and solutions.
Encap Drug Delivery has 1 investor. Key investors include Capsugel.
Yes. Encap Drug Delivery was acquired by Capsugel in March 2013.